Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Proxima, Laserscope, Medtronic Qualify For Improved Outpatient Payments

This article was originally published in The Gray Sheet

Executive Summary

Adoption of Proxima Therapeutics' MammoSite high-dose rate brachytherapy catheter for early-stage breast cancer will increase with its placement into a new-technology APC, the firm maintains

You may also be interested in...



American Medical Buys Laserscope For GreenLight Obstructive BPH Treatment

American Medical Systems will expand its benign prostatic hyperplasia treatment offerings to include operating room-based obstructive BPH therapy with Laserscope's GreenLight surgical laser system under a June 5 acquisition agreement

American Medical Buys Laserscope For GreenLight Obstructive BPH Treatment

American Medical Systems will expand its benign prostatic hyperplasia treatment offerings to include operating room-based obstructive BPH therapy with Laserscope's GreenLight surgical laser system under a June 5 acquisition agreement

Cytyc Pays 10-Times Sales For Proxima, Breast Cancer Therapy Market Entry

Cytyc likely will divest Proxima Therapeutics' GliaSite brain tumor radiation therapy system after acquiring the company for its MammoSite breast cancer system under a $160 mil. deal Feb. 9

Related Content

UsernamePublicRestriction

Register

MT020065

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel